Enterprise Value
-12.65M
Cash
44.57M
Avg Qtr Burn
-13.78M
Short % of Float
4.32%
Insider Ownership
13.13%
Institutional Own.
42.97%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
NYX-783 Details Psychiatric disorder, Post-traumatic stress disorder | Failed Discontinued | |
NYX-2925 Details Central nervous system illness, Fibromyalgia | Failed Discontinued | |
NYX-458 Details Central nervous system illness, Mental health, Parkinson's disease | Failed Discontinued | |
NYX-2925 Details Diabetic peripheral neuropathy | Failed Discontinued |